Osteoporosis
📧 Sign up to get email alerts when something new happens for Osteoporosis.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-02-24EMA Authorised: Acvybra (denosumab) — Reddy Holding GmbH
The European Medicines Agency has authorised Acvybra (denosumab) from Reddy Holding GmbH for osteoporosis-related conditions, including post…
-
EMA approval · 2026-02-24EMA Authorised: Zoledronic Acid Accord (zoledronic acid monohydrate) — Accord Healthcare S.L.U.
The EMA authorised Zoledronic Acid Accord (zoledronic acid monohydrate) for hypercalcemia, prevention of fractures in bone disorders, and ca…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes [Phase 3]
A Phase 3 clinical trial sponsored by Emory University is evaluating whether GLP-1 receptor agonist therapy can impact osteosarcopenia in ol…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Assesment and Comparison of Osteoporosis Risk Factors After Stroke
A clinical trial at Ankara Etlik City Hospital is assessing osteoporosis risk factors after stroke and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Dairy vs Plant-based Beverages for Improving Bone Health During Exercise [NA]
The University of Saskatchewan is recruiting participants for a trial comparing dairy versus plant-based beverages to improve bone health du…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Health Literacy and Osteoporosis Awareness
A recruiting clinical trial at Bandırma Onyedi Eylül University is studying osteoporosis in the context of health literacy and awareness.
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: A Study Evaluating the Performance of Using AI Software and Chest X-rays to Screen for Osteoporosis as Compared to Standard DXA Scans in Patients 50 Years and Older
A clinical trial evaluating AI software plus chest X-rays to screen for osteoporosis in adults 50 years and older, compared with standard DX…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Assess Safety and Compare PK of New Oral hPTH(1-34) Tablet Formulations vs. EBP05 Tablets and Subcutaneous Forteo [Phase 1]
Phase 1 trial assessing safety and pharmacokinetics of new oral hPTH(1-34) tablet formulations, compared with EBP05 tablets and subcutaneous…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Romosozumab Use to Build Skeletal Integrity [Phase 4]
Phase 4 trial update shows romosozumab for enhancing skeletal integrity in osteoporosis (including postmenopausal osteoporosis and osteoporo…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Minimally Invasive Sinus Lift Through the Interradicular Septum [NA]
A clinical trial sponsored by Universidad de Murcia is recruiting for a minimally invasive sinus lift through the interradicular septum to a…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Contribution of Bone to Urine Citrate
This clinical trial investigates the contribution of bone to urine citrate in adults with osteoporosis and is currently enrolling by invitat…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD) [NA]
A clinical trial update for REMS25 evaluating REMS technology in diseases commonly associated with reduced bone mineral density; recruitment…
-
EMA approval · 2026-02-12EMA Authorised: Fosavance (alendronic acid;colecalciferol) — Organon N.V.
EMA authorised Fosavance (alendronic acid and colecalciferol) by Organon N.V. for osteoporosis, including postmenopausal osteoporosis.
-
EMA approval · 2026-02-12EMA Authorised: Adrovance (colecalciferol;alendronic acid (as sodium trihydrate)) — Organon N.V.
The European Medicines Agency authorised Adrovance, a fixed-dose combination of colecalciferol (vitamin D3) and alendronic acid (as sodium t…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Evaluation of Efficacy and Safety of Prolia in Subjects of Male Osteoporosis in Mainland China [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of Prolia (denosumab) in men with osteoporosis in Mainland China; the study is cur…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: The Comparison of Ibandronate and Zoledronic Acid After Denosumab Discontinuation [Phase 4]
Phase 4 clinical trial comparing ibandronate to zoledronic acid after denosumab discontinuation in postmenopausal osteoporosis and osteopeni…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Female Osteoporosis
This document notes a clinical trial related to osteoporosis in women that is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Intravenous Infusion of Human Mesenchymal Stem Cells (HMM910 ) in Postmenopausal Women With Osteoporosis at High Risk of Fracture [Phase 1]
Phase 1 study evaluating intravenous HMM910, a human mesenchymal stem cell therapy, in postmenopausal women with osteoporosis at high fractu…
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Preserving Geriatric Muscle With an Osteoporosis Medication [Phase 4]
A Phase 4 trial is evaluating whether a medication used for osteoporosis can help preserve muscle mass in older adults; the study is current…
-
CLINICAL_TRIALS withdrawal · 2026-02-10Clinical Trial Update: Study of a Bone Assessment Technique, Bone Mineral Analyser, Concerning the Prediction of Improvement in Bone Status After an Infusion of Zoledronic Acid in Osteoporotic Women [NA]
This document notes the withdrawal of a clinical trial evaluating a bone assessment technique to predict improvement in bone status after zo…
-
EMA approval · 2026-02-06EMA Authorised: Bildyos (denosumab) — Sciencepharma Sp. z o.o
EMA authorised Bildyos, a denosumab medicine by Sciencepharma Sp. z o.o., for osteoporosis and postmenopausal osteoporosis related to bone r…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Prunes Preventing Bone Loss in Perimenopause [NA]
Penn State University is sponsoring a recruiting clinical trial to test whether prune (dried plum) consumption can help prevent bone loss in…
-
FDA approval · 2026-02-03FDA Approved: IBANDRONATE SODIUM — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for ibandronate sodium by Macleods Pharmaceuticals Limited.
-
FDA approval · 2026-02-03FDA Approved: ALENDRONATE SODIUM — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' supplemental application for alendronate sodium, updating the approved product under the ANDA.
-
FDA approval · 2026-02-03FDA Approved: IBANDRONATE SODIUM — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for ibandronate sodium submitted by Dr. Reddy's Laboratories Limited.